EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into Merck and AbbVie regarding drug trials conducted in China.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
House committee initiated an investigation into Merck and AbbVie's drug trials in China, focusing on ties to military-linked hospitals. Lawmakers also pressed Eli Lilly and other drugmakers for information regarding their clinical trials in China.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 18d ago, after coverage quieted.
The brief
A US House committee is investigating drug trials in China conducted by Merck and AbbVie. According to Quartz, the investigation centers on trials tied to the Chinese military.
Coverage from Reuters and Endpoints News emphasizes that the House China panel is also questioning other pharmaceutical companies, specifically Bristol Myers and Pfizer, regarding trial sites. Pharmaphorum reports that drugmakers have been asked to defend these trials.
Market reactions are already appearing, with Investing.com Nigeria noting a slip in AbbVie stock. Future developments depend on the outcomes of the House panel's inquiries into these trial sites.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 20d ago.
Quick answers
Which companies are being investigated?
The US House committee has opened an investigation into Merck and AbbVie, while also questioning Bristol Myers and Pfizer.
What is the focus of the investigation?
The investigation concerns drug trials in China, with Quartz reporting links to the Chinese military.
How has the market responded?
Investing.com Nigeria reported that AbbVie stock is slipping today.
Coverage (10)
- U.S. Congress Investigates Chinese Clinical Trials Tied to Military Capabilities 조선일보 · 20d ago
- Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals AOL.com · 20d ago
- Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals Fox News · 21d ago
- U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report Pharmaceutical Executive · 21d ago
- Why is AbbVie stock slipping today? By Investing.com Investing.com Nigeria · 21d ago
- Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more statnews.com · 21d ago
- Drugmakers asked to defend Chinese trials; reports pharmaphorum · 21d ago
- Congress is investigating Merck and AbbVie over drug trials in China tied to its military qz.com · 21d ago
- Exclusive: House China panel questions Bristol Myers, Pfizer on trial sites Endpoints News · 21d ago
- EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials Reuters · 21d ago
Topics
Related trends
Shanghai science forum photos show China’s AI and robotics advances in rivalry with US
Visuals from a Shanghai science forum highlight China's robotics and AI advancements amid a growing technological rivalry with the US.
China weighs tighter export controls on AI models and chips
China is considering stricter export controls on AI models and chips as global adoption of its technology increases.
China Broadens Market Rescue With Record Inflows Into Tech ETF
China's 'national team' has deployed nearly $9 billion in share purchases to stabilize markets following a recent rout.
Japan protests Chinese live-fire drill in nearby waters
Japan has filed a protest after Chinese and Russian warships conducted rare live-fire exercises within Japan's Exclusive Economic Zone.
The secret Trump administration battle to fight Chinese AI
The U.S. administration is weighing sanctions and increased scrutiny of Chinese AI models over allegations of intellectual property theft.
China AI Sensation Moonshot’s Gamble on Big Models Pays Off
Moonshot AI's Kimi K3 model is disrupting the global market by undercutting American competitors on price with a massive 2.8T open-weight model.